MENU

News

FDA approves new drug to treat influenza

U.S. Food & Drug Administration
October 24, 2018

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.